DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Wilens TE, Verlinden MH, Adler LA. et al.
ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit hyperactivity disorder in adults: results of a pilot study.
Biol Psychiatry 2006; 59: 1065-1070
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.